(Q44484408)

3 December 2017

title

Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

3 December 2017

main subject

1 reference

1 reference

3 December 2017

Trevor T Hansel

1 reference

3 December 2017

Ferran Morell

1 reference

3 December 2017

Klaus F Rabe

1 reference

3 December 2017

Elizabeth Gamble

1 reference

3 December 2017

Diana C Grootendorst

1 reference

3 December 2017

Christopher E Brightling

1 reference

3 December 2017

Susannah Troy

1 reference

3 December 2017

Yusheng Qiu

1 reference

3 December 2017

Jie Zhu

1 reference

3 December 2017

Debbie Parker

1 reference

3 December 2017

Dean Matin

1 reference

3 December 2017

Swati Majumdar

1 reference

3 December 2017

Antonio M Vignola

1 reference

3 December 2017

Claus Kroegel

1 reference

3 December 2017

Stephen I Rennard

1 reference

3 December 2017

Christopher Compton

1 reference

3 December 2017

Ohad Amit

1 reference

3 December 2017

Tri Tat

1 reference

3 December 2017

Jeffrey Edelson

1 reference

3 December 2017

Neil C Barnes

1 reference

3 December 2017

Peter K Jeffery

1 reference

3 December 2017

language of work or name

English

0 references

publication date

19 June 2003

1 reference

American Journal of Respiratory and Critical Care Medicine

3 December 2017

published in

1 reference

3 December 2017

volume

168

1 reference

3 December 2017

1 reference

3 December 2017

page(s)

976-982

1 reference

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Comparison of the structural and inflammatory features of COPD and asthma. Giles F. Filley Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Interleukin-4 and interleukin-5 gene expression and inflammation in the mucus-secreting glands and subepithelial tissue of smokers with chronic bronchitis. Lack of relationship with CD8(+) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Tumor necrosis factor-alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

The use of induced sputum to investigate airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Cellular and structural bases of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Amplification of inflammation in emphysema and its association with latent adenoviral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

The macrophage in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

The cellular composition of induced sputum in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1490OC

10.1164/RCCM.200212-1490OC

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference